$0.27
0.00 (-0.60%)
Open$0.27
Previous Close$0.27
Day High$0.29
Day Low$0.27
52W High$0.50
52W Low$0.24
Volume—
Avg Volume701.4K
Market Cap27.52M
P/E Ratio—
EPS$-0.07
SectorPharmaceuticals
Analyst Ratings
Strong Buy
6 analysts
Price Target
+5,801.9% upside
Current
$0.27
$0.27
Target
$15.64
$15.64
$13.90
$15.64 avg
$22.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 980.9K | 996.0K | 13.95M |
| Net Income | -4,674,264 | -4,271,768 | 2.16M |
| Profit Margin | -477.1% | -453.3% | 15.5% |
| EBITDA | -8,357,625 | -8,062,290 | 3.52M |
| Free Cash Flow | — | — | 2.06M |
| Rev Growth | -1.5% | -1.5% | +17.1% |
| Debt/Equity | 0.02 | 0.02 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |